Cariprazine + Placebo

ApprovedCompleted

1 views this week 0 watching⚡ Active

Interest: 43/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

✓

Phase 3

Approved

Indication / Disease

Social Anxiety Disorder

Conditions

Social Anxiety Disorder

Trial Timeline

Jul 18, 2022 → Apr 15, 2024

NCT ID

NCT05384483

About Cariprazine + Placebo

Cariprazine + Placebo is a approved stage product being developed by AbbVie for Social Anxiety Disorder. The current trial status is completed. This product is registered under clinical trial identifier NCT05384483. Target conditions include Social Anxiety Disorder.

What happened to similar drugs?

6 of 15 similar drugs in Social Anxiety Disorder were approved

Approved (6) Terminated (4) Active (6)

✅QuetiapineAstraZenecaApproved

✅quetiapineAstraZenecaApproved

✅Pristiq + PlaceboPfizerApproved

✅Sertraline + PlaceboPfizerApproved

✅NefazodoneBristol Myers SquibbApproved

✅EscitalopramLundbeckApproved

❌quetiapineAstraZenecaPhase 3

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (7)

NCT ID	Phase	Status	Start	Completion	Indication
NCT05368558	Phase 3	Terminated	Aug 18, 2022	Sep 20, 2024	Schizophrenia
NCT05384483	Approved	Completed	Jul 18, 2022	Apr 15, 2024	Social Anxiety Disorder
NCT05439616	Phase 3	Completed	Jul 7, 2022	Oct 4, 2024	Autism Spectrum Disorder
NCT04777357	Phase 3	Recruiting	Apr 28, 2021	Mar 1, 2027	Depression
NCT03738215	Phase 3	Completed	Nov 9, 2018	Sep 30, 2021	Major Depressive Disorder
NCT03593213	Phase 3	Terminated	Jul 30, 2018	Feb 11, 2021	Schizophrenia
NCT03573297	Phase 3	Completed	Jun 15, 2018	Sep 5, 2022	Bipolar I Disorder

Competing Products

20 competing products in Social Anxiety Disorder

See all competitors

Product	Company	Stage	Hype Score
LY686017 + paroxetine + placebo	Eli Lilly	Phase 2	35
atomoxetine + placebo	Eli Lilly	Phase 2/3	38
ONO-1110 + Placebo	Ono Pharmaceutical	Phase 2	39
Quetiapine	AstraZeneca	Approved	43
quetiapine	AstraZeneca	Phase 3	32
quetiapine	AstraZeneca	Phase 2/3	38
Seroquel + Sugar Pill	AstraZeneca	Phase 3	40
quetiapine	AstraZeneca	Approved	43
Pristiq + Placebo	Pfizer	Approved	43
Venlafaxine ER	Pfizer	Phase 3	40
Ziprasidone + Sertraline	Pfizer	Phase 2	35
Sertraline + Placebo	Pfizer	Approved	35
Nefazodone	Bristol Myers Squibb	Approved	43
Escitalopram	Lundbeck	Approved	40
Cipralex + Placebo	Lundbeck	Phase 2	32
BHV-0223 + Placebo	Biohaven	Phase 2/3	32
VQW-765 + Placebo	Vanda Pharmaceuticals	Phase 3	37
PH94B	Vistagen Therapeutics	Phase 3	22
Fasedienol Nasal Spray - Placebo Nasal Spray + Fasedienol Nasal Spray - Fasedienol Nasal Spray + Placebo Nasal Spray - Placebo Nasal Spray	Vistagen Therapeutics	Phase 2	32
PH94B Nasal Spray + Placebo Nasal Spray	Vistagen Therapeutics	Phase 3	22